Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Feb 16;7(1):6.
doi: 10.1186/s40169-017-0180-3.

Recent advances in hyaluronic acid based therapy for osteoarthritis

Steven Bowman  1 , Mohamed E Awad  2 , Mark W Hamrick  3   4 , Monte Hunter  1 , Sadanand Fulzele  5   6
Affiliations
Review

Recent advances in hyaluronic acid based therapy for osteoarthritis

Steven Bowman et al. Clin Transl Med. .

Abstract

Osteoarthritis is a debilitating disease that has increased in prevalence across the world due to the aging population. Currently, physicians use a plethora of treatment strategies to try and slow down the progression of the disease, but none have been shown to ubiquitously treat and cure the disease. One of the strategies uses the high molecular weight molecule hyaluronic acid as either an injectable or oral supplement for treatment. Hyaluronic acid (HA) is a relatively new treatment that has shown varied results through several clinical trials. It can be used as a scaffold for engineering new treatments and several new preparations have just been added to the market. A comprehensive search was conducted through several search databases according our inclusion and exclusion criteria. This review included 44 prospective clinical trial investigating the feasibility and efficacy of HA injection for knee, hip, and ankle osteoarthritis. This review will take a closer look at hyaluronic acid and its properties, as well clinical effectiveness and future options.

Keywords: Hyaluronic acid (HA); Osteoarthritis; Tissue engineering; Treatment.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow chart showing study identification, inclusion, and exclusion
See this image and copyright information in PMC

References

    1. Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!) Osteoarthr Cartil. 2013;21(1):16–21. doi: 10.1016/j.joca.2012.11.012. - DOI - PubMed
    1. CDC Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2010–2012. MMWR. 2013;62:869–873. - PMC - PubMed
    1. Barbour K, et al. Meeting physical activity guidelines and the risk of incident knee osteoarthritis: the Johnston County Osteoarthritis Project. Arthritis Care Res (Hoboken) 2014;66(1):139–146. doi: 10.1002/acr.22120. - DOI - PMC - PubMed
    1. Moskowitz RW. The burden of osteoarthritis: clinical and quality-of-life issues. Am J Manag Care. 2009;15(8 Suppl):S223–S229. - PubMed
    1. Puig-Junoy J, Ruiz Zamora A. Socio-economic costs of osteoarthritis: a systematic review of cost-of-illness studies. Semin Arthritis Rheum. 2015;44(5):531–541. doi: 10.1016/j.semarthrit.2014.10.012. - DOI - PubMed